Tag: AQST-108
Emergency Epinephrine Film Begins Phase 1 Clinical Trials
First healthy volunteer dosed in a Phase 1 study of AQST-108 for the treatment of allergic reactions including anaphylaxis.
Aquestive’s Sublingual Epinephrine Film Receives FDA Fast Track Designation for Treatment...
First planned PK clinical trial expected to begin during the third quarter of 2020.
Aquestive Files IND to Begin Clinical Trials of Sublingual Epinephrine
Epinephrine you slip under your tongue takes another step forward as the company submits their IND application.
FDA Opens Door for Clinical Development of Aquestive Therapeutics Anaphylaxis Treatment
Emergency epinephrine candidate dissolves in the mouth.
Update on Delivery of Emergency Epinephrine via Sublingual Film
Aquestive is finalizing the clinical trial application for a 2019Q2 study.
